Digital health accelerator ANDHealth and biomedical commercialisation fund Brandon BioCatalyst have been awarded $50 million to launch another round of their CUREator+ BioMedTech program to support commercialisation and translation of research targeting dementia and cognitive decline.
Friday’s funding announcement from Health minister Mark Butler was a part of $230 million worth of new commitments made out through the Medical Research Future Fund (MRFF). The BioMedTech grant represented the single largest …
Want to know how this story ends?
Become a subscriber for complete access to all stories on InnovationAus.com and our daily newsletter.
Already a member? Log in here
Do you know more? Contact James Riley via Email.